Absolute Donor‐Recipient Serum Sodium Difference Predicts Early Allograft Dysfunction After Liver Transplantation: A Retrospective Cohort Study
Clinical Transplantation · 2026-11 · 40 (11)
DOI: 10.1111/ctr.70628 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Transplantation, online erschienen am 14.11.2026. Verfasst von Wanzhen Cai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Liver Transplantation, Sodium, Tissue Donors, Graft Rejection. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Background
Serum sodium level serves as an important indicator for evaluating marginal liver grafts. However, the relationship between the donor‑recipient serum sodium difference and recipient prognosis after liver transplantation remains insufficiently investigated. This study aimed to determine whether the donor‑recipient serum sodium difference predicts early allograft dysfunction (EAD) and patient survival following liver transplantation.
Methods
In this retrospective cohort study, we included 214 donor‑recipient pairs who underwent liver transplantation at the First Affiliated Hospital of Sun Yat‑sen University between January 2018 and July 2023. Multivariate logistic regression analysis was performed to identify risk factors for EAD. The predictive performance of the donor‑recipient serum sodium difference was evaluated using receiver operating characteristic (ROC) curves. Based on the optimal cut‑off value of 9.5 mmol/L, patients were categorized into high‑ and low‑sodium difference groups. Postoperative outcomes, liver function recovery, and survival were compared between the two groups.
Results
The donor‑recipient serum sodium difference was significantly associated with the risk of EAD (OR = 1.030, 95% CI: 1.004–1.056, P < 0.05). Its predictive performance for EAD (AUC = 0.618) was superior to that of donor serum sodium alone (AUC = 0.597). Using the 9.5 mmol/L cut‑off, the high‑difference group ( n = 69) exhibited significantly higher incidences of EAD (44.92% vs. 26.90%), 30‑day mortality (11.59% vs. 2.76%), and 1‑year mortality (18.84% vs. 8.28%) compared with the low‑difference group ( n = 145) (all P < 0.05). The high‑difference group also showed delayed recovery of postoperative liver function and significantly poorer graft and patient survival (Log‑rank P < 0.05).
Conclusion
The absolute donor‑recipient serum sodium difference independently predicts early allograft dysfunction and short‑term mortality after liver transplantation, providing valuable information for clinical risk stratification and prognostic assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Zitieren
APA
Cai, W., Chen, R., Qian, X., Lui, K. Y., Ma, H., & Cai, C. (2026). Absolute Donor‐Recipient Serum Sodium Difference Predicts Early Allograft Dysfunction After Liver Transplantation: A Retrospective Cohort Study. Clinical Transplantation, 40(11). https://doi.org/10.1111/ctr.70628
Vancouver
Cai W, Chen R, Qian X, Lui KY, Ma H, Cai C. Absolute Donor‐Recipient Serum Sodium Difference Predicts Early Allograft Dysfunction After Liver Transplantation: A Retrospective Cohort Study. Clinical Transplantation. 2026;40(11). doi:10.1111/ctr.70628
BibTeX
@article{Cai2026,
author = {Cai, Wanzhen and Chen, Rongping and Qian, Xiayan and Lui, Ka Yin and Ma, Huan and Cai, Changjie},
title = {Absolute Donor‐Recipient Serum Sodium Difference Predicts Early Allograft Dysfunction After Liver Transplantation: A Retrospective Cohort Study},
journal = {Clinical Transplantation},
year = {2026},
volume = {40},
number = {11},
doi = {10.1111/ctr.70628}
}
EUVIMED